12 HR propafenone hydrochloride 325 MG Extended Release Oral Capsule — RxCUI 861164
RxNorm drug concept · Semantic clinical drug
RxCUI 861164
Semantic clinical drug · SCD
● Current RxNorm concept 27 FDA products
50 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI861164
Official name12 HR propafenone hydrochloride 325 MG Extended Release Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known aspropafenone HCl 325 MG 12HR Extended Release Oral Capsule
FDA products mapped27
Package NDCs mapped50
Reported Medicaid activity (SDUD)621 prescriptions · 9 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Propafenone: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Think of it as an electrical 'slow-down' for your heart. Your heart has channels that carry electrical signals triggering each beat — propafenone partially blocks those channels so...
- What exactly is propafenone doing for my heart?
- Yes, a few important ones. Grapefruit juice can raise propafenone levels in your blood, so it's best to avoid it. Several medications — including some antidepressants like paroxeti...
- Are there foods or common medications I should avoid while taking this?
🕸️ Concept Web — How 12 HR propafenone hydrochloride 325 MG Extended... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
12 HR propafenone hydrochloride 325 MG Extended Release Oral Capsule
RxCUI 861164 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Propafenone
8754IN -
Propafenone hydrochloride
203135PIN
-
Propafenone
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Rythmol
82079BN
-
Rythmol
-
Dose forms 13
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Propafenone Extended Release Oral Capsule
406230SCDF -
Propafenone hydrochloride Extended Release Oral Capsule
2648753SCDFP -
Propafenone Oral Product
1162317SCDG -
Propafenone Pill
1162318SCDG -
Propafenone hydrochloride Oral Product
2663268SCDGP -
Propafenone hydrochloride Pill
2662243SCDGP -
Propafenone Extended Release Oral Capsule [Rythmol]
861158SBDF -
Propafenone hydrochloride Extended Release Oral Capsule [Rythmol]
2654909SBDFP - +5 more in this family
-
Propafenone Extended Release Oral Capsule
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Propafenone hydrochloride 325 MG
861163SCDC -
12 HR propafenone hydrochloride 325 MG Extended Release Oral Capsule [Rythmol]
861167SBD -
Propafenone hydrochloride 325 MG [Rythmol]
861165SBDC
-
Propafenone hydrochloride 325 MG
Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Propafenone hydrochloride 325 MG
SCDC · 861163 -
Propafenone Extended Release Oral Capsule
SCDF · 406230 -
Propafenone hydrochloride Extended Release Oral Capsule
SCDFP · 2648753 -
Propafenone Oral Product
SCDG · 1162317 -
Propafenone Pill
SCDG · 1162318 -
Propafenone hydrochloride Oral Product
SCDGP · 2663268 -
Propafenone hydrochloride Pill
SCDGP · 2662243
Brand-Name Concepts
-
12 HR propafenone hydrochloride 325 MG Extended Release Oral Capsule [Rythmol]
SBD · 861167 -
Propafenone hydrochloride 325 MG [Rythmol]
SBDC · 861165 -
Propafenone Extended Release Oral Capsule [Rythmol]
SBDF · 861158 -
Propafenone hydrochloride Extended Release Oral Capsule [Rythmol]
SBDFP · 2654909 -
Rythmol Oral Product
SBDG · 1183688 -
Rythmol Pill
SBDG · 1183689 -
Rythmol
BN · 82079
📦 FDA Products & Package NDCs
27 products · 50 package NDCs
50 package NDCs map to RxCUI 861164 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00832-0740-60 | 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0832-0740-60) | Propafenone Hydrochloride | Upsher-Smith Laboratories, LLC | 2020-06-25 |
| 00832-0741-60 | 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0832-0741-60) | Propafenone Hydrochloride | Upsher-Smith Laboratories, LLC | 2020-06-25 |
| 00832-0742-60 | 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0832-0742-60) | Propafenone Hydrochloride | Upsher-Smith Laboratories, LLC | 2020-06-25 |
| 16571-0736-06 | 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (16571-736-06) | PROPAFENONE HYDROCHLORIDE | Rising Pharma Holdings, Inc. | 2020-12-16 |
| 16571-0736-50 | 500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (16571-736-50) | PROPAFENONE HYDROCHLORIDE | Rising Pharma Holdings, Inc. | 2020-12-16 |
| 16571-0737-06 | 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (16571-737-06) | PROPAFENONE HYDROCHLORIDE | Rising Pharma Holdings, Inc. | 2020-12-16 |
| 16571-0737-50 | 500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (16571-737-50) | PROPAFENONE HYDROCHLORIDE | Rising Pharma Holdings, Inc. | 2020-12-16 |
| 16571-0738-06 | 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (16571-738-06) | PROPAFENONE HYDROCHLORIDE | Rising Pharma Holdings, Inc. | 2020-12-16 |
| 16571-0738-50 | 500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (16571-738-50) | PROPAFENONE HYDROCHLORIDE | Rising Pharma Holdings, Inc. | 2020-12-16 |
| 16714-0825-01 | 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (16714-825-01) | propafenone hydrochloride | Northstar Rx LLC | 2018-07-16 |
| 16714-0826-01 | 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (16714-826-01) | propafenone hydrochloride | Northstar Rx LLC | 2018-07-16 |
| 16714-0827-01 | 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (16714-827-01) | propafenone hydrochloride | Northstar Rx LLC | 2018-07-16 |
| 59651-0276-05 | 500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (59651-276-05) | Propafenone Hydrochloride | Aurobindo Pharma Limited | 2023-02-21 |
| 59651-0276-60 | 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (59651-276-60) | Propafenone Hydrochloride | Aurobindo Pharma Limited | 2023-02-21 |
| 59651-0276-90 | 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (59651-276-90) | Propafenone Hydrochloride | Aurobindo Pharma Limited | 2023-02-21 |
| 59651-0277-05 | 500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (59651-277-05) | Propafenone Hydrochloride | Aurobindo Pharma Limited | 2023-02-21 |
| 59651-0277-60 | 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (59651-277-60) | Propafenone Hydrochloride | Aurobindo Pharma Limited | 2023-02-21 |
| 59651-0277-90 | 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (59651-277-90) | Propafenone Hydrochloride | Aurobindo Pharma Limited | 2023-02-21 |
| 59651-0278-05 | 500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (59651-278-05) | Propafenone Hydrochloride | Aurobindo Pharma Limited | 2023-02-21 |
| 59651-0278-60 | 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (59651-278-60) | Propafenone Hydrochloride | Aurobindo Pharma Limited | 2023-02-21 |
| 59651-0278-90 | 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (59651-278-90) | Propafenone Hydrochloride | Aurobindo Pharma Limited | 2023-02-21 |
| 64380-0184-01 | 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (64380-184... | Propafenone Hydrochloride | Strides Pharma Science Limited | 2022-04-04 |
| 64380-0184-02 | 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (64380-184... | Propafenone Hydrochloride | Strides Pharma Science Limited | 2022-04-04 |
| 64380-0184-04 | 500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (64380-18... | Propafenone Hydrochloride | Strides Pharma Science Limited | 2022-09-30 |
| 64380-0185-01 | 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (64380-185... | Propafenone Hydrochloride | Strides Pharma Science Limited | 2022-04-04 |
| 64380-0185-02 | 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (64380-185... | Propafenone Hydrochloride | Strides Pharma Science Limited | 2022-04-04 |
| 64380-0185-04 | 500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (64380-18... | Propafenone Hydrochloride | Strides Pharma Science Limited | 2022-09-30 |
| 64380-0186-01 | 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (64380-186... | Propafenone Hydrochloride | Strides Pharma Science Limited | 2022-04-04 |
| 64380-0186-04 | 500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (64380-18... | Propafenone Hydrochloride | Strides Pharma Science Limited | 2022-04-04 |
| 68382-0522-05 | 500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68382-522-05) | Propafenone Hydrochloride | Zydus Pharmaceuticals (USA) Inc. | 2022-02-02 |
| 68382-0522-14 | 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68382-522-14) | Propafenone Hydrochloride | Zydus Pharmaceuticals (USA) Inc. | 2022-02-02 |
| 68382-0523-05 | 500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68382-523-05) | Propafenone Hydrochloride | Zydus Pharmaceuticals (USA) Inc. | 2022-02-02 |
| 68382-0523-14 | 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68382-523-14) | Propafenone Hydrochloride | Zydus Pharmaceuticals (USA) Inc. | 2022-02-02 |
| 68382-0524-05 | 500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68382-524-05) | Propafenone Hydrochloride | Zydus Pharmaceuticals (USA) Inc. | 2022-02-02 |
| 68382-0524-14 | 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68382-524-14) | Propafenone Hydrochloride | Zydus Pharmaceuticals (USA) Inc. | 2022-02-02 |
| 68462-0408-60 | 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68462-408-60) | propafenone hydrochloride | Glenmark Pharmaceuticals Inc., USA | 2017-09-08 |
| 68462-0409-60 | 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68462-409-60) | propafenone hydrochloride | Glenmark Pharmaceuticals Inc., USA | 2017-09-08 |
| 68462-0410-60 | 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68462-410-60) | propafenone hydrochloride | Glenmark Pharmaceuticals Inc., USA | 2017-09-08 |
| 69680-0130-60 | 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (69680-130... | Propafenone Hydrochloride | Vitruvias Therapeutics | 2019-01-28 |
| 69680-0130-92 | 500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (69680-13... | Propafenone Hydrochloride | Vitruvias Therapeutics | 2019-01-28 |
| 69680-0131-60 | 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (69680-131... | Propafenone Hydrochloride | Vitruvias Therapeutics | 2019-01-28 |
| 69680-0131-92 | 500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (69680-13... | Propafenone Hydrochloride | Vitruvias Therapeutics | 2019-01-28 |
| 69680-0132-60 | 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (69680-132... | Propafenone Hydrochloride | Vitruvias Therapeutics | 2019-01-28 |
| 69680-0132-92 | 500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (69680-13... | Propafenone Hydrochloride | Vitruvias Therapeutics | 2019-01-28 |
| 70771-1525-05 | 500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (70771-1525-5) | Propafenone Hydrochloride | Zydus Lifesciences Limited | 2022-02-02 |
| 70771-1525-06 | 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (70771-1525-6) | Propafenone Hydrochloride | Zydus Lifesciences Limited | 2022-02-02 |
| 70771-1526-05 | 500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (70771-1526-5) | Propafenone Hydrochloride | Zydus Lifesciences Limited | 2022-02-02 |
| 70771-1526-06 | 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (70771-1526-6) | Propafenone Hydrochloride | Zydus Lifesciences Limited | 2022-02-02 |
| 70771-1527-05 | 500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (70771-1527-5) | Propafenone Hydrochloride | Zydus Lifesciences Limited | 2022-02-02 |
| 70771-1527-06 | 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (70771-1527-6) | Propafenone Hydrochloride | Zydus Lifesciences Limited | 2022-02-02 |
Observed labelers:
Aurobindo Pharma Limited (9) ·
Strides Pharma Science Limited (8) ·
Rising Pharma Holdings, Inc. (6) ·
Vitruvias Therapeutics (6) ·
Zydus Lifesciences Limited (6) ·
Zydus Pharmaceuticals (USA) Inc. (6)
· +3 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.